MarketBeat
Definium Therapeutics Teases 3 Key DT-120 Data Readouts This Year, Highlights De-Risked Phase 3 Design
📈
AI Sentiment
Highly Positive
9/10
Definium Therapeutics Inc. Common Shares News
Latest updates and market news for DFTX
2 news
Mar 18 - Mar 24, 2026
Page 1
Motley Fool
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names
📈
AI Sentiment
Highly Positive
8/10
Share this news page